We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A large-scale observational study of chronic kidney disease (CKD) is due to launch in general practices this month, involving 3,205 Oxfordshire residents and led by Oxford University researchers.
Today, the National Kidney Foundation (NKF) has reached a scientific seminar with the Food and Drug Administration (FDA) and the European Medicines Agency (EMA)
A team of researchers set out to discover the disease pathways of a rare genetic kidney disease and consequently found a compound that stops the disease in its tracks.